Synapse - Christian Grommes

Results (156)

Primary central nervous system lymphoma

Review

Ferreri, A. J. M.; Calimeri, T.; Cwynarski, K.; Dietrich, J.; Grommes, C.; Hoang-Xuan, K.; Hu, L. S.; Illerhaus, G.; Nayak, L.; Ponzoni, M.; more...
Nature Reviews Disease Primers (2023)

Fulltext@MSK | Save

Detecting CXCR4 expression in meningioma on (68)Ga-pentixafor PET/MRI

Journal Article

Krebs, S.; Schwartz, J.; Grommes, C.; Young, R. J.; Schöder, H.; Mayerhoefer, M. E.
Journal of Nuclear Medicine (2023)

Fulltext@MSK | Save

Circulating tumor DNA in the blood: A new frontier in primary CNS lymphoma?

Editorial

Grommes, C.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Trial in progress: A phase 1b/2 study of GB5121, a brain-penetrant, potent, highly selective, and irreversible BTK inhibitor for relapsed/refractory primary/secondary CNS lymphoma and primary vitreoretinal lymphoma

Meeting Abstract

Soussain, C.; Issa, S.; Lewis, K. L.; Grommes, C.; Fox, J.; Ward, R.; Peterson, C.; Cravets, M.; Mathias, A.; Sosa, J.; more...
Blood (2022)

Fulltext@MSK | Save

Radiotherapy for secondary CNS lymphoma: Patterns of utilization and clinical outcomes

Meeting Abstract

Cederquist, G. Y.; Tringale, K. R.; Hajj, C.; Hubbeling, H.; Fregonese, B.; Lee, J.; Scordo, M.; Grommes, C.; Yahalom, J.; Imber, B. S.
Blood (2022)

Fulltext@MSK | Save

Impact on tumour treatment and outcome of SARS-CoV-2 infection in 91 patients with primary CNS lymphoma: A real-life study of the international PCNSL Collaborative Group

Meeting Abstract

Calimeri, T.; Steffanoni, S.; Laurenge, A.; Fox, C. P.; Soussain, C.; Grommes, C.; Tisi, M. C.; Boot, J.; Crosbie, N.; Visco, C.; more...
Blood (2022)

Fulltext@MSK | Save

Phase Ib/II trial of the Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, in combination with rituximab and lenalidomide in refractory/recurrent primary (PCNSL) and secondary central nervous system lymphoma (SCNSL)

Meeting Abstract

Grommes, C.; Piotrowski, A.; Pentsova, E.; Gavrilovic, I.; Stone, J. B.; Lin, A.; Wongchai, V.; Madzsar, J. T.; Malani, R.; Nolan, C.; more...
Blood (2022)

Fulltext@MSK | Save

Initial treatment response is prognostic and predictive of relapse patterns: Outcomes of >500 patients treated for primary CNS lymphoma

Meeting Abstract

Tringale, K. R.; Yahalom, J.; Scordo, M.; Cederquist, G. Y.; Vachha, B.; Schaff, L.; Hajj, C.; Hubbeling, H.; Zhang, Z.; White, C.; more...
Blood (2022)

Fulltext@MSK | Save

Unilateral panuveitis secondary to JAK2 mutation-associated lymphoproliferative disease

Journal Article

Li, Y.; Grommes, C.; Deobhakta, A.; Diaz, M.
BMJ Case Reports (2022)

Fulltext@MSK | Save

Non-invasive diagnosis of IDH-mutant brainstem gliomas

Meeting Abstract

Kushnirsky, M.; Thakur, S.; Karajannis, M.; Bale, T.; Rosenblum, M.; Malani, R.; Gavrilovic, I. T.; Schaff, L.; Pentsova, E.; Grommes, C.; more...
Neuro-Oncology (2022)

Fulltext@MSK | Save